+1 (704) 266-3234

COVID-19 Impact On Global Parkinson's Disease Therapeutics Market Size, Status And Forecast 2020-2026

Published on: Jun 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 125

This report focuses on the global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Merck
Akorn
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

Market segment by Type, the product can be split into
Medications Therapeutics
Medical Devices Therapeutics
Market segment by Application, split into
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Parkinson's Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson's Disease Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications Therapeutics
1.4.3 Medical Devices Therapeutics
1.5 Market by Application
1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Coronavirus Disease 2019 (Covid-19): Parkinson's Disease Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Parkinson's Disease Therapeutics Industry
1.6.1.1 Parkinson's Disease Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Parkinson's Disease Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Parkinson's Disease Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Parkinson's Disease Therapeutics Market Perspective (2015-2026)
2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Parkinson's Disease Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Parkinson's Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Market Size
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.2.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2019
3.3 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Parkinson's Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Parkinson's Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2015-2020)
6.2 Parkinson's Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2020)
7.2 Parkinson's Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Parkinson's Disease Therapeutics Market Size (2015-2020)
8.2 Parkinson's Disease Therapeutics Key Players in China (2019-2020)
8.3 China Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
8.4 China Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2020)
9.2 Parkinson's Disease Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
9.4 Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2020)
10.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Parkinson's Disease Therapeutics Market Size (2015-2020)
11.2 Parkinson's Disease Therapeutics Key Players in India (2019-2020)
11.3 India Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
11.4 India Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Parkinson's Disease Therapeutics Market Size (2015-2020)
12.2 Parkinson's Disease Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview and Its Total Revenue
13.1.3 GSK Parkinson's Disease Therapeutics Introduction
13.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Parkinson's Disease Therapeutics Introduction
13.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Details
13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
13.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.3.5 Boehringer Ingelheim Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
13.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Abbvie
13.5.1 Abbvie Company Details
13.5.2 Abbvie Business Overview and Its Total Revenue
13.5.3 Abbvie Parkinson's Disease Therapeutics Introduction
13.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.5.5 Abbvie Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview and Its Total Revenue
13.6.3 Merck Parkinson's Disease Therapeutics Introduction
13.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Akorn
13.7.1 Akorn Company Details
13.7.2 Akorn Business Overview and Its Total Revenue
13.7.3 Akorn Parkinson's Disease Therapeutics Introduction
13.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.7.5 Akorn Recent Development
13.8 Kyowa Hakko Kirin Pharma
13.8.1 Kyowa Hakko Kirin Pharma Company Details
13.8.2 Kyowa Hakko Kirin Pharma Business Overview and Its Total Revenue
13.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
13.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.8.5 Kyowa Hakko Kirin Pharma Recent Development
13.9 Astellas Pharma
13.9.1 Astellas Pharma Company Details
13.9.2 Astellas Pharma Business Overview and Its Total Revenue
13.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
13.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.9.5 Astellas Pharma Recent Development
13.10 Desitin Arzneimittel
13.10.1 Desitin Arzneimittel Company Details
13.10.2 Desitin Arzneimittel Business Overview and Its Total Revenue
13.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
13.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
13.10.5 Desitin Arzneimittel Recent Development
13.11 Endo Pharmaceuticals
10.11.1 Endo Pharmaceuticals Company Details
10.11.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
10.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
10.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.11.5 Endo Pharmaceuticals Recent Development
13.12 F.Hoffmann-La Roche
10.12.1 F.Hoffmann-La Roche Company Details
10.12.2 F.Hoffmann-La Roche Business Overview and Its Total Revenue
10.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction
10.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.12.5 F.Hoffmann-La Roche Recent Development
13.13 H.Lundbeck
10.13.1 H.Lundbeck Company Details
10.13.2 H.Lundbeck Business Overview and Its Total Revenue
10.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
10.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.13.5 H.Lundbeck Recent Development
13.14 Valeant
10.14.1 Valeant Company Details
10.14.2 Valeant Business Overview and Its Total Revenue
10.14.3 Valeant Parkinson's Disease Therapeutics Introduction
10.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.14.5 Valeant Recent Development
13.15 Apokyn
10.15.1 Apokyn Company Details
10.15.2 Apokyn Business Overview and Its Total Revenue
10.15.3 Apokyn Parkinson's Disease Therapeutics Introduction
10.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.15.5 Apokyn Recent Development
13.16 Orion
10.16.1 Orion Company Details
10.16.2 Orion Business Overview and Its Total Revenue
10.16.3 Orion Parkinson's Disease Therapeutics Introduction
10.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.16.5 Orion Recent Development
13.17 Stada Arzneimittel
10.17.1 Stada Arzneimittel Company Details
10.17.2 Stada Arzneimittel Business Overview and Its Total Revenue
10.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
10.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.17.5 Stada Arzneimittel Recent Development
13.18 US WorldMeds
10.18.1 US WorldMeds Company Details
10.18.2 US WorldMeds Business Overview and Its Total Revenue
10.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
10.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.18.5 US WorldMeds Recent Development
13.19 Bausch Health
10.19.1 Bausch Health Company Details
10.19.2 Bausch Health Business Overview and Its Total Revenue
10.19.3 Bausch Health Parkinson's Disease Therapeutics Introduction
10.19.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.19.5 Bausch Health Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Parkinson's Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
Table 3. Ranking of Global Top Parkinson's Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications Therapeutics
Table 6. Key Players of Medical Devices Therapeutics
Table 7. COVID-19 Impact Global Market: (Four Parkinson's Disease Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Parkinson's Disease Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Parkinson's Disease Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Parkinson's Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Parkinson's Disease Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Parkinson's Disease Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Parkinson's Disease Therapeutics Players
Table 23. Global Parkinson's Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Parkinson's Disease Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019)
Table 26. Global Parkinson's Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 29. Date of Enter into Parkinson's Disease Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Parkinson's Disease Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Parkinson's Disease Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Parkinson's Disease Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 39. North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 41. North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 45. Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 51. China Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 53. China Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 57. Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 69. India Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 71. India Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Parkinson's Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Parkinson's Disease Therapeutics Market Share (2019-2020)
Table 75. Central & South America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim Product
Table 92. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 93. Boehringer Ingelheim Recent Development
Table 94. Teva Pharmaceutical Company Details
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Product
Table 97. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 98. Teva Pharmaceutical Recent Development
Table 99. Abbvie Company Details
Table 100. Abbvie Business Overview
Table 101. Abbvie Product
Table 102. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 103. Abbvie Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. Akorn Company Details
Table 110. Akorn Business Overview
Table 111. Akorn Product
Table 112. Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 113. Akorn Recent Development
Table 114. Kyowa Hakko Kirin Pharma Business Overview
Table 115. Kyowa Hakko Kirin Pharma Product
Table 116. Kyowa Hakko Kirin Pharma Company Details
Table 117. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 118. Kyowa Hakko Kirin Pharma Recent Development
Table 119. Astellas Pharma Company Details
Table 120. Astellas Pharma Business Overview
Table 121. Astellas Pharma Product
Table 122. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 123. Astellas Pharma Recent Development
Table 124. Desitin Arzneimittel Company Details
Table 125. Desitin Arzneimittel Business Overview
Table 126. Desitin Arzneimittel Product
Table 127. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 128. Desitin Arzneimittel Recent Development
Table 129. Endo Pharmaceuticals Company Details
Table 130. Endo Pharmaceuticals Business Overview
Table 131. Endo Pharmaceuticals Product
Table 132. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 133. Endo Pharmaceuticals Recent Development
Table 134. F.Hoffmann-La Roche Company Details
Table 135. F.Hoffmann-La Roche Business Overview
Table 136. F.Hoffmann-La Roche Product
Table 137. F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 138. F.Hoffmann-La Roche Recent Development
Table 139. H.Lundbeck Company Details
Table 140. H.Lundbeck Business Overview
Table 141. H.Lundbeck Product
Table 142. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 143. H.Lundbeck Recent Development
Table 144. Valeant Company Details
Table 145. Valeant Business Overview
Table 146. Valeant Product
Table 147. Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 148. Valeant Recent Development
Table 149. Apokyn Company Details
Table 150. Apokyn Business Overview
Table 151. Apokyn Product
Table 152. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 153. Apokyn Recent Development
Table 154. Orion Company Details
Table 155. Orion Business Overview
Table 156. Orion Product
Table 157. Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 158. Orion Recent Development
Table 159. Stada Arzneimittel Company Details
Table 160. Stada Arzneimittel Business Overview
Table 161. Stada Arzneimittel Product
Table 162. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 163. Stada Arzneimittel Recent Development
Table 164. US WorldMeds Company Details
Table 165. US WorldMeds Business Overview
Table 166. US WorldMeds Product
Table 167. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 168. US WorldMeds Recent Development
Table 169. Bausch Health Company Details
Table 170. Bausch Health Business Overview
Table 171. Bausch Health Product
Table 172. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (Million US$)
Table 173. Bausch Health Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Medications Therapeutics Features
Figure 3. Medical Devices Therapeutics Features
Figure 4. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Under 40 Years Old Case Studies
Figure 6. 40-65 Years Old Case Studies
Figure 7. Above 65 Years Old Case Studies
Figure 8. Parkinson's Disease Therapeutics Report Years Considered
Figure 9. Global Parkinson's Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Parkinson's Disease Therapeutics Market Share by Players in 2019
Figure 14. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2019
Figure 16. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 27. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 29. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 31. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 35. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 37. Kyowa Hakko Kirin Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 39. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 41. Desitin Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 43. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 45. F.Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 47. H.Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 49. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Valeant Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 51. Apokyn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 53. Orion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 55. Stada Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 57. US WorldMeds Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 59. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.